NANOVIS® Corporate News

Nanosurface Technology on Spinal Interbody

First use of novel bioceramic enhanced nanotube surface in the world.

CARMEL, Indiana. (July 30, 2019) – Nanovis today announced the commercial launch of its bioceramic nanotube enhanced FortiCore interbodies following a successful alpha launch.

The FortiCore interbodies are designed with a unique, proprietary, patent protected bio-ceramic enhanced titanium nanotube surface. The nanotubes are applied to a deeply porous, fully interconnected titanium scaffold intermolded with a PEEK core for preferred modulus and plain x-ray visualization.

Top 10 Orthopedic Solution Provider 2019

Company recognized for its nanotechnology-based spinal devices

CARMEL, Indiana. (May 8, 2019) – Nanovis today announced that MedTech Outlook recognized Nanovis as a Top 10 Orthopedic Solution Provider, 2019. Its industry-leading fixation technologies offer surgeons and hospitals the best aspects of fixation, visualization, and durability. Nanovis’ developmental infection technology platforms promise to offer surgeons and hospitals much-needed bactericidal solutions.

Posterior Lumbar Interbody Fusion System

CARMEL, Ind., November 14, 2018— Nanovis, a leader in nanomedicine for the spine, today announced adding 22mm and 25mm lengths to its FortiCore® rotatable Posterior Lumbar Interbody Fusion (PLIF) devices.

With over 5,000 FortiCore interbodies now implanted, Nanovis plans to further accelerate its technology driven growth with the expansion of their FortiCore PLIF product line with the addition of 22 mm and 25 mm lengths that can be rotated in situ for optimal placement.

This foundational nanotechnology patent, covering the use of ceramics on spinal implants with nanopores, builds on Nanovis’ superior portfolio of fixation technologies.

CARMEL, Indiana. – Sept. 11, 2018 – Nanovis, a leader in nanomedicine for the spine, today announced a licensing agreement with the University of Nevada, Reno for a key nanosurface technology patent covering the use of ceramics on implants with nanopores.
This foundational patent allows development of ceramics for medical implants with nanosurfacing that enhances cell binding and drug delivery depending on the purpose of implantation.

This funding supports surging demand from surgeons and distributors for Nanovis’ nano-technology enhanced spinal implants.

Carmel, Ind. (Aug. 21, 2018) Nanovis, an innovative and fast-growing technology company selling nano-technology enhanced spinal implants, announced today the successful completion of a $5.5 million funding round brokered by Commenda Securities. Key investors include Elevate Ventures, 1st Source Capital Corporation, Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures.

Latest Post

Search